<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0026">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Kalirajan</surname>
    <given-names>R.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Pandiselvi</surname>
    <given-names>A.</given-names>
   </name>, 
   <name name-style="western">
    <surname>Gowramma</surname>
    <given-names>B.</given-names>
   </name>, &amp; 
   <name name-style="western">
    <surname>Balachandran</surname>
    <given-names>P.</given-names>
   </name>
  </person-group> (
  <year>2019</year>). 
  <article-title>
   <italic>In-silico</italic> design, ADMET screening, MM-GBSA binding free energy of some novel isoxazole substituted 9-anilinoacridines as HER2 inhibitors targeting breast cancer
  </article-title>. 
  <source>
   <italic toggle="yes">Current Drug Research Reviews</italic>
  </source>, (
  <issue>2</issue>), 
  <fpage>118</fpage>â€“
  <lpage>128</lpage>. 
  <pub-id pub-id-type="doi">10.2174/2589977511666190912154817</pub-id>
  <pub-id pub-id-type="pmid">31513003</pub-id>
 </mixed-citation>
</ref>
